This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
Opening Price | Stop Loss | Profit Limit | Reward vs Risk | CFD Margin |
155.8p | 148p (7.8p/-5.0% below) | 172p (16.2p/10.4% above) | 2.1x | 5% |
Observations – For
Observations – Against
Shares bounced off 150p support. By virtue of its size MRW is likely the only UK grocer to be an M&A target. Market placing (middle-market) means safer play of the incumbents given intense price competition from German discounters. The CEO bought 300K shares at 158.79p 10 days ago.
Bloomberg consensus is fairly evenly split. Consensus target price implies 17% upside and to summer highs beyond the trend of falling March resistance. 78% of brokers have target prices above the current share price.
Next Event: Ex-div, 1 Oct; Half-year results, 5 Nov
Latest Broker 12-Month Consensus: 30% Buy, 35% Hold, 35% Sell (full breakdown on request)
Source: DowJones Newswires, Reuters News, Boomberg or Company Press releases
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research